News for Longevity Acquisition Corporation (LOAC)

4d Pharma develops a novel class of drugs termed live biotherapeutic products. What are the risks? What are my views on LBPS stock? Click here to find out.

/PRNewswire/ -- Sir Bruce Keogh, Chairman of the Board Lord Paul Drayson, CEO Sensyne Health PLC Science Park Schrödinger Building Heatley Rd Oxford OX4 4GE...

4D pharma plc (Nasdaq: LBPS; AIM: DDDD) ("4D pharma" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs)

NEW YORK, Feb. 26, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated?Top 50?in the 2018 and 2019 ISS... | February 27, 2021

/PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS...

NEW YORK, Feb. 26, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated  Top

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Longevity Acquisition Corp. ("LOAC" or the "Company") (LOAC) relating to its proposed merger with 4D Pharma PLC. Under the terms of the agreement, LOAC shareholders will receive 7.5315 shares of 4D Pharma per share.

4D pharma plc , a pharmaceutical company leading the development of Live Biotherapeutic products , a novel class of drug derived from the microbiome, today announced a clinical trial collaboration... | February 8, 2021

Home Press releases 4D pharma announces clinical trial collaboration with Merck KGaA and Pfizer to evaluate MRx0518 in combination with... | February 8, 2021

Mailing Address YONGDA INTERNATIONAL TOWER NO. 2277 LONGEVITY ROAD PUDONG DISTRICT SHANGHAI F4 20000 Business Address YONGDA INTERNATIONAL TOWER NO. 2277 LONGE...

WILMINGTON, Del., Jan. 07, 2021 -- Rigrodsky & Long, P.A. announces that it is investigating: Sunesis Pharmaceuticals, Inc. regarding possible breaches of fiduciary duties and other...